Among the 12 significant genes involved in the immunosuppression of GBM, CCL2 recruits Tregs and myeloid-derived suppressor cells, which play a critical role in the immunosuppressive glioma microenvironment [20]. The gene discussed is CCL2; the disease is central nervous system cancer.